Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen

被引：0
|
作者：
Krzakowski, M.
Douillard, J.
Ramlau, R.
Jassem, J.
Szczesna, A.
Zatloukal, P.
von Pawel, J.
Hansen, O.
Sun, X.
机构：
[1] Oncol Ctr Inst M Sklodowska Curie, Warsaw, Poland
[2] Ctr Rene Gauducheau, Nantes, France
[3] Reg Lung Dis Hosp, Poznan, Poland
[4] Med Univ, Gdansk, Poland
[5] Reg Lung Dis Hosp, Otwock, Poland
[6] Charles Univ Prague, Prague, Czech Republic
[7] Asklepios Fachkliniken Munchen, Gauting, Germany
[8] Odense Univ Hosp, Odense, Denmark
[9] Hop Andre Boulloche, Montbeliard, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7511
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II trial of pevonedistat plus docetaxel in patients with previously treated advanced non-small-cell lung cancer (NSCLC)
    Wells, Leah
    Qin, Angel
    Rice, John
    Gadgeel, Shirish M.
    Schneider, Bryan J.
    Ramnath, Nithya
    Zhao, Lili
    Kalemkerian, Gregory Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study
    Wu, Yi-Long
    Lu, Shun
    Cheng, Ying
    Zhou, Caicun
    Wang, Jie
    Mok, Tony
    Zhang, Li
    Tu, Haiyan
    Wu, Lin
    Feng, Jifeng
    Zhang, Yiping
    Luft, Alexander Valeriercich
    Zhou, Jianying
    Ma, Zhiyong
    Lu, You
    Hu, Chengping
    Shi, Yuankai
    Baudelet, Christine
    Li, Zoe
    Chang, Jianhua
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
  • [44] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
    Felip, E
    Rojo, F
    Heller, A
    Foernzler, D
    Majo, J
    Klughammer, B
    Ramos, J
    Maacke, H
    Brennscheidt, U
    Baselga, J
    LUNG CANCER, 2005, 49 : S369 - S369
  • [45] Phase II study of amrubicin (AMR) in patients (pts) with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: WJTOG0401
    Hayashi, H.
    Kaneda, H.
    Okamoto, I.
    Miyazaki, M.
    Kudoh, S.
    Sawa, T.
    Takeda, K.
    Negoro, S.
    Iwamoto, Y.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Nakamura, A.
    Yoneshima, Y.
    Morita, S.
    Ando, M.
    Iwasawa, S.
    Yoshioka, H.
    Goto, Y.
    Takeshita, M.
    Harada, T.
    Hirano, K.
    Oguri, T.
    Kondo, M.
    Miura, S.
    Hosomi, Y.
    Kato, T.
    Kubo, T.
    Kishimoto, J.
    Yamamoto, N.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S107 - S108
  • [47] A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer
    Shimizu, Tetsuo
    Nakagawa, Yoshiko
    Asai, Yasuo
    Tsujino, Ichirou
    Takahashi, Noriaki
    Gon, Yasuhiro
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (07) : 3079 - 3087
  • [48] Weekly docetaxel (TXT) and cisplatin (CIS) for chemonaive patients (Pts) with advanced non-small cell lung cancer (NSCLC)
    Aisner, J
    Geunsch, L
    Schwarz, S
    Zheng, L
    Wojtaszek, C
    Lutzker, S
    LUNG CANCER, 2005, 49 : S233 - S233
  • [49] Phase ii trial with Docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)
    Latreille, J
    Laberge, F
    Viallet, J
    Maksymiuk, A
    Shepherd, F
    Gelman, K
    Delorme, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1070 - 1070
  • [50] KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)
    Zhou, C.
    Caglevic, C.
    Zhou, J.
    Wang, B.
    Wang, K.
    Ge, J.
    Zhou, Y.
    Piperdi, B.
    Ma, Z.
    ANNALS OF ONCOLOGY, 2017, 28 : 143 - 143
12345